What comes next for Mayo’s COVID-19 plasma program?

The New York Times is reporting this week that a group of top federal health officials have privately voiced concern about a prominent COVID-19 research program run by the Mayo Clinic. The program is testing the use of blood plasma from recovered patients to treat those who are seriously ill with the virus.

Mayo Clinic recently reported promising results, and enrollment in the program has surged. But according to the Times, Dr. Anthony Fauci and other top health officials stepped in last week to block what's known as an “emergency use authorization” for the plasma treatment.

For more, MPR News host Cathy Wurzer talked with Dr. Scott Wright, who is helping oversee the Mayo Clinic’s convalescent plasma program.

Your support matters.

You make MPR News possible. Individual donations are behind the clarity in coverage from our reporters across the state, stories that connect us, and conversations that provide perspectives. Help ensure MPR remains a resource that brings Minnesotans together.